RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0042-1744233
Metastatic Primary Neuroendocrine Tumor of Ovary—A Rare Presentation
Autor*innen
Abstract
Neuroendocrine tumors (NETs) occur more commonly in lungs, gastrointestinal tract, or pancreas. NETs in locations such as ovaries are rare, and they have been described mainly in case reports. Here we describe a patient with primary NET of ovary presenting with distant metastases to peritoneum, liver, lung, and mediastinal lymph nodes.
Patient Consent
Written informed consent was obtained from the patient for publication of this case report and the accompanying images.
Publikationsverlauf
Artikel online veröffentlicht:
23. Juni 2022
© 2022. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Klimstra DS, Modlin IR, Adsay NV. et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol 2010; 34 (03) 300-313
- 2 Yao JC, Hassan M, Phan A. et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26 (18) 3063-3072
- 3 Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 79 (04) 813-829
- 4 Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97 (04) 934-959
- 5 Robboy SJ, Norris HJ, Scully RE. Insular carcinoid primary in the ovary. A clinicopathologic analysis of 48 cases. Cancer 1975; 36 (02) 404-418
- 6 Reed NS, Gomez-Garcia E, Gallardo-Rincon D. et al. Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary. Int J Gynecol Cancer 2014; 24 (09, Suppl 3): S35-S41
- 7 Vora M, Lacour RA, Black DR, Turbat-Herrera EA, Gu X. Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation. Arch Gynecol Obstet 2016; 293 (03) 659-665
- 8 Hsu W-W, Mao T-L, Chen C-H. Primary ovarian mucinous carcinoid tumor: a case report and review of literature. Taiwan J Obstet Gynecol 2019; 58 (04) 570-573
- 9 McCluggage WG, Young RH. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin Diagn Pathol 2005; 22 (01) 3-32
- 10 Desouki MM, Lioyd J, Xu H, Cao D, Barner R, Zhao C. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Hum Pathol 2013; 44 (11) 2536-2541
- 11 Kurabayashi T, Minamikawa T, Nishijima S. et al. Primary strumal carcinoid tumor of the ovary with multiple bone and breast metastases. J Obstet Gynaecol Res 2010; 36 (03) 567-571
- 12 Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol 2011; 122 (01) 190-198